The board of directors of West Pharmaceutical Services Inc (NYSE:WST), a drug company declared on Wednesday its dividend of USD0.18 per share of its stock for the Q1 2022.

This dividend is payable on 2 February 2022 to shareholders of record as of 19 January 2022.

For calendar-year 2022, the board of directors authorized a share repurchase programme of up to 650,000 shares of the company's common stock from time to time on the open market or in privately negotiated transactions, as permitted under Exchange Act Rule 10b-18.

This share repurchase plan is expected to be completed by 31 December 2022, subject to several factors, including market conditions.